{"id":"mtx-hold","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2074706","moleculeType":"Small molecule","molecularWeight":"466.50"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The exact mechanism is unclear from available public data, but 'MTX-hold' likely refers to a modified methotrexate administration protocol or delivery system under investigation at Seoul National University Hospital. Methotrexate is a folate antagonist and antimetabolite that inhibits dihydrofolate reductase, suppressing cell proliferation and immune responses. The 'hold' designation may indicate a novel dosing schedule, formulation, or combination strategy.","oneSentence":"MTX-hold is a methotrexate dosing strategy or formulation designed to optimize therapeutic efficacy while managing toxicity in autoimmune or oncologic conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:22:15.810Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00005596","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-04","conditions":"Leukemia","enrollment":1076},{"nctId":"NCT05069714","phase":"PHASE3","title":"One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2021-10-01","conditions":"Rheumatoid Arthritis, Autoimmune Diseases, Influenza","enrollment":184},{"nctId":"NCT05313061","phase":"PHASE3","title":"MTX Hold During Covid-19 Booster","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2021-12-29","conditions":"Rheumatoid Arthritis","enrollment":40},{"nctId":"NCT02748785","phase":"PHASE4","title":"MTX Discontinuation and Vaccine Response","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2015-09","conditions":"Arthritis, Rheumatoid","enrollment":277},{"nctId":"NCT02897011","phase":"NA","title":"2-week dc of MTX and Influenza Vaccination in RA","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2016-09","conditions":"Rheumatoid Arthritis, Influenza, Methotrexate","enrollment":318}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MTX-hold","genericName":"MTX-hold","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}